Urothelial Carcinoma — Trials

Urothelial Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

624 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 237
Recruiting: 119
Ph III recruiting: 14
Growth YoY: +40%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 44.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02573259	A Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid Tumors	completed	Phase 1	147	PfizerINDUSTRY	7	Dec 13, 2021	clinicaltrials
NCT03652077	A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies	completed	Phase 1	40	Incyte CorporationINDUSTRY	1	Nov 15, 2021	clinicaltrials